
Sign up to save your podcasts
Or


In this episode of Nurse Chat Diaries, host Daman explores the multifaceted world of diabetes, discussing its impact on individuals and communities. Through real-life stories, the episode highlights the importance of understanding diabetes, the latest innovations in management, and the critical role of prevention. Daman emphasizes that diabetes is not just about numbers but about real people and the opportunities to change health outcomes.
American Diabetes Association. (2025). Standards ofmedical care in diabetes—2025. Diabetes Care, 48(Suppl. 1), S1–S200.https://doi.org/10.2337/dc25-S001
Centers for Disease Control and Prevention. (2025). Nationaldiabetes statistics report, 2025. U.S. Department of Health and HumanServices. https://www.cdc.gov/diabetes
Frias, J. P., Nauck, M. A., Van J., Kutner, M. E., Cui, X.,Benson, C., Urva, S., Gimeno, R. E., & Milicevic, Z. (2021). Efficacy andsafety of tirzepatide, a dual GIP and GLP-1 receptor agonist, in patients withtype 2 diabetes (SURPASS-2): A randomised, open-label, phase 3 trial. TheNew England Journal of Medicine, 385(6), 503–515.https://doi.org/10.1056/NEJMoa2107519
World Health Organization. (2025). Global report ondiabetes: 2025 update. Geneva: WHO. https://www.who.int/publications
Instagram: @nursechatdiariespodcast
TikTok: @nurse.chat.diaries
Twitter (X): @chat_diaries
By DamanIn this episode of Nurse Chat Diaries, host Daman explores the multifaceted world of diabetes, discussing its impact on individuals and communities. Through real-life stories, the episode highlights the importance of understanding diabetes, the latest innovations in management, and the critical role of prevention. Daman emphasizes that diabetes is not just about numbers but about real people and the opportunities to change health outcomes.
American Diabetes Association. (2025). Standards ofmedical care in diabetes—2025. Diabetes Care, 48(Suppl. 1), S1–S200.https://doi.org/10.2337/dc25-S001
Centers for Disease Control and Prevention. (2025). Nationaldiabetes statistics report, 2025. U.S. Department of Health and HumanServices. https://www.cdc.gov/diabetes
Frias, J. P., Nauck, M. A., Van J., Kutner, M. E., Cui, X.,Benson, C., Urva, S., Gimeno, R. E., & Milicevic, Z. (2021). Efficacy andsafety of tirzepatide, a dual GIP and GLP-1 receptor agonist, in patients withtype 2 diabetes (SURPASS-2): A randomised, open-label, phase 3 trial. TheNew England Journal of Medicine, 385(6), 503–515.https://doi.org/10.1056/NEJMoa2107519
World Health Organization. (2025). Global report ondiabetes: 2025 update. Geneva: WHO. https://www.who.int/publications
Instagram: @nursechatdiariespodcast
TikTok: @nurse.chat.diaries
Twitter (X): @chat_diaries